CorMedix Inc banner

CorMedix Inc
F:19KA

Watchlist Manager
CorMedix Inc Logo
CorMedix Inc
F:19KA
Watchlist
Price: 6.574 EUR 1.99% Market Closed
Market Cap: €361.4m

Wall St Price Targets

19KA Price Targets Summary
CorMedix Inc

Wall Street analysts forecast 19KA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 19KA is 18.652 EUR with a low forecast of 16.477 EUR and a high forecast of 25.036 EUR.

Lowest Forecast
Price Target
16.477 EUR
151% Upside
Average Forecast
Price Target
18.652 EUR
184% Upside
Highest Forecast
Price Target
25.036 EUR
281% Upside
CorMedix Inc Competitors:
Price Targets
SITOWS
Sitowise Group Oyj
6% Upside

Revenue
Forecast

N/A
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

The compound annual growth rate for Revenue over the next 8 years is 15%.

Operating Income
Forecast

N/A
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss
N/A
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss

The compound annual growth rate for Operating Income over the next 8 years is 20%.

Net Income
Forecast

N/A
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-61%
Average Miss
N/A
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-61%
Average Miss

The compound annual growth rate for Net Income over the next 8 years is 13%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 19KA's stock price target?
Price Target
18.652 EUR

According to Wall Street analysts, the average 1-year price target for 19KA is 18.652 EUR with a low forecast of 16.477 EUR and a high forecast of 25.036 EUR.

What is the Revenue forecast for CorMedix Inc?
Projected CAGR
15%

The compound annual growth rate for Revenue over the next 8 years is 15%.

What is the Operating Income forecast for CorMedix Inc?
Projected CAGR
20%

The compound annual growth rate for Operating Income over the next 8 years is 20%.

What is the Net Income forecast for CorMedix Inc?
Projected CAGR
13%

The compound annual growth rate for Net Income over the next 8 years is 13%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett